e-ISSN: Pending
Failure-mode index

Search what already failed

A searchable index of real negative results, null findings, and replication failures from the published literature — so you can learn what didn't work before repeating it.

WASTE indexes published research — it does not host or republish full papers. Each entry is a metadata record (title, authors, DOI) compiled from open scholarly databases, with the abstract shown in full only where the paper is openly licensed (e.g. Creative Commons); otherwise a short excerpt is shown for reference under fair use. WASTE classifies each work by failure type; classifications are automated and approximate.

403 results in Replication Failure · page 4 of 14

Replication FailureOpen accessMedicine

Rectal diclofenac versus indomethacin for prevention of post-ERCP pancreatitis (DIPPP): a multicentre, double-blind, randomised, controlled trial

Xiaoyu Kang, Mingxing Xia, Jun Wang et al. · 2025 · Gut

BACKGROUND: Recent meta-analyses suggested diclofenac may be superior to indomethacin in preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). The aim of our study was to compare the efficacy of 100 mg…

View details →DOI: 10.1136/gutjnl-2024-334466Cited by 14
Replication FailureOpen accessMedicine

Inhibition of FcRn with rozanolixizumab in adults with immune thrombocytopenia: Two randomised, double‐blind, placebo‐controlled phase 3 studies and their open‐label extension

Nichola Cooper, James B. Bussel, Maciej Kaźmierczak et al. · 2024 · British Journal of Haematology

Summary Primary immune thrombocytopenia (ITP) is an antiplatelet‐antibody‐mediated disorder with accelerated platelet clearance and decreased platelet production. Rozanolixizumab, a monoclonal IgG4 anti‐FcRn antibody, blocks IgG recycling and decreases IgG levels. We report efficacy and safety of rozanolixizumab in adults with persistent/chronic ITP in 24‐week phase 3 studies (TP0003; TP0006), and their 52‐week open‐label extension (OLE). Primary end‐point was durable clinically meaningful platelet response (DCMPR) of ≥50 × 10 9 /L for 8/12 weeks during Weeks 13–25 in the double‐blind studies.

View details →DOI: 10.1111/bjh.19858Cited by 13
Replication FailureOpen accessMedicine

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate‐stage Hepatocellular Carcinoma: A Multicenter Retrospective Study

Yitao Zheng, Yan‐Jun Xiang, Hongqi Shi et al. · 2024 · Journal of Hepatocellular Carcinoma

Purpose: Combining transarterial chemoembolization (TACE) with systemic therapy has shown significant efficacy for intermediate-stage hepatocellular carcinoma (HCC) patients. This study aimed to validate the therapeutic efficacy of TACE…

View details →DOI: 10.2147/jhc.s461630Cited by 13
Replication FailureOpen accessMedicine

Long-Term Outcomes of Left Bundle-Branch Pacing vs Biventricular Pacing in Heart Failure

Xueying Chen, Xi Liu, Ruogu Li et al. · 2026 · JAMA Cardiology

Importance: Left bundle-branch pacing (LBBP) has been proposed as an alternative to biventricular pacing (BiVP) for patients with heart failure with left bundle-branch block (LBBB). However, robust clinical evidence from randomized clinical trials is lacking. Objective: To evaluate the long-term clinical outcomes of LBBP and BiVP. Design, Setting, and Participants: This multicenter, prospective, randomized clinical trial enrolled 200 patients at 6 centers in China with a left ventricular ejection fraction (LVEF) of 35% or less and LBBB from October 2020 to March 2022. This study was took place

View details →DOI: 10.1001/jamacardio.2026.0083Cited by 12
Replication FailureOpen accessMedicine

Ticagrelor vs Prasugrel in Patients With Diabetes and Multivessel Coronary Artery Disease

S Bangalore, Santosh Kumar Sinha, Rakendra Singh et al. · 2026 · JAMA Cardiology

Importance: The optimal dual antiplatelet therapy after percutaneous coronary intervention (PCI) in patients with diabetes is not clearly defined. Although both ticagrelor and prasugrel are potent inhibitors of P2Y purinergic receptor 12…

View details →DOI: 10.1001/jamacardio.2025.5057Cited by 11
Replication FailureOpen accessChemistry

Herbify: an ensemble deep learning framework integrating convolutional neural networks and vision transformers for precise herb identification

Farhan Sheth, Ishika Chatter, Manvendra Jasra et al. · 2025 · Plant Methods

Herbs have historically been central to medicinal practices, representing one of the earliest forms of therapeutic intervention. While synthetic drugs are often highly effective in treating acute conditions, their use is frequently…

View details →DOI: 10.1186/s13007-025-01421-5Cited by 11
Replication FailureOpen accessNeuroscience

Pridopidine in early-stage manifest Huntington’s disease: a phase 3 trial

Ralf Reilmann, Andrew Feigin, Anne Rosser et al. · 2025 · Nature Medicine

Huntington's disease (HD) is a rare, neurodegenerative disorder for which only symptomatic treatments are available. The PROOF-HD study was a randomized, double-blind, placebo-controlled phase 3 trial evaluating the efficacy and safety of pridopidine, a selective Sigma-1 receptor agonist, in HD. The primary and key secondary endpoints, change in total functional capacity (TFC) and composite Unified Huntington's Disease Rating Scale (cUHDRS) score at week 65, were not met in the overall population. The TFC least-squares mean difference between pridopidine and placebo was -0.18 (95% confidence i

View details →DOI: 10.1038/s41591-025-03920-3Cited by 11
Replication FailureOpen accessPsychology

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression

Lea J. Mertens, Michael Koslowski, Felix Betzler et al. · 2026 · JAMA Psychiatry

Importance: Psilocybin shows promise in treating depression, although limitations of previous research warrant further research. Objective: To investigate the efficacy and safety of oral psilocybin, 25 mg, with adjunct psychotherapy in…

View details →DOI: 10.1001/jamapsychiatry.2026.0132Cited by 10
Replication FailureOpen accessMedicine

Randomized trial investigating the utility of a liver tissue transcriptional biomarker in identifying adult liver transplant recipients not requiring maintenance immunosuppression

Julien Vionnet, Jorge P. Torres-Yaguana, Rosa Miquel et al. · 2024 · American Journal of Transplantation

The maintenance of stable allograft status in the absence of immunosuppression (IS), known as operational tolerance, can be achieved in a small proportion of liver transplant recipients, but we lack reliable tools to predict its spontaneous development. We conducted a prospective, multicenter, biomarker-strategy design, IS withdrawal clinical trial to determine the utility of a predictive biomarker of operational tolerance. The biomarker test, originally identified in a patient cohort with high operational tolerance prevalence, consisted of a 5-gene transcriptional signature measured in liver

View details →DOI: 10.1016/j.ajt.2024.12.002Cited by 10
Replication FailureOpen accessMedicine

Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate hepatocellular carcinoma: a single-arm, phase 2 trial

Kang Wang, Jinkai Feng, Hongming Yu et al. · 2025 · Signal Transduction and Targeted Therapy

Transarterial chemoembolization (TACE) is the standard treatment for intermediate-stage hepatocellular carcinoma (HCC), yet its efficacy as a standalone therapy remains suboptimal. This phase 2 trial (ChiCTR2100049829) evaluated the feasibility and safety of TACE combined with atezolizumab and bevacizumab in patients with intermediate-stage HCC. Participants received TACE followed by atezolizumab and bevacizumab until disease progression, unacceptable toxicity, or death. The primary endpoint was objective response rate (ORR) assessed per Response Evaluation Criteria in Solid Tumors (RECIST) v1

View details →DOI: 10.1038/s41392-025-02427-0Cited by 10
Replication FailureBiochemistry, Genetics and Molecular Biology

Identification of Statistically Significant Features from Random Forests

Jérôme Paul, Michel Verleysen, Pierre Dupont · 2013

Abstract. Embedded feature selection can be performed by analyzing the variables used in a Random Forest. Such a multivariate selection takes into account the interactions between variables but is not easy to interpret in a statistical…

View details →Cited by 10
Replication FailureOpen accessImmunology and Microbiology

A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma

Tomoki Makino, Hiroshi Miyata, Takushi Yasuda et al. · 2024 · Esophagus

BACKGROUND: S-588410, a cancer peptide vaccine (CPV), comprises five HLA-A*24:02-restricted peptides from five cancer-testis antigens. In a phase 2 study, S-588410 was well-tolerated and exhibited antitumor efficacy in patients with urothelial cancer. Therefore, we aimed to evaluate the efficacy, immune response, and safety of S-588410 in patients with completely resected esophageal squamous cell carcinoma (ESCC). METHODS: This phase 3 study involved patients with HLA-A*24:02-positive and lymph node metastasis-positive ESCC who received neoadjuvant therapy followed by curative resection. After

View details →DOI: 10.1007/s10388-024-01072-wCited by 10
Replication FailureOpen accessBiochemistry, Genetics and Molecular Biology

A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer

Dennis Poel, Elske C. Gootjes, Lotte Bakkerus et al. · 2020 · Cancer Medicine

BACKGROUND: Palliative systemic therapy is currently standard of care for patients with extensive metastatic colorectal cancer (mCRC). A biomarker predicting chemotherapy benefit which prevents toxicity from ineffective treatment is urgently needed. Therefore, a previously developed tissue-derived microRNA profile to predict clinical benefit from chemotherapy was evaluated in tissue biopsies and serum from patients with mCRC. METHODS: Samples were prospectively collected from patients (N = 132) who were treated with capecitabine or 5-FU/LV with oxaliplatin ± bevacizumab. Response evaluation wa

View details →DOI: 10.1002/cam4.3371Cited by 10
Replication FailureOpen accessMedicine

CAR T-Cell Targeting of Macrophage Colony-Stimulating Factor Receptor

Daniela Achkova, Richard Beatson, John Maher · 2022 · Cells

Macrophage colony-stimulating factor receptor (M-CSFR) is found in cells of the mononuclear phagocyte lineage and is aberrantly expressed in a range of tumours, in addition to tumour-associated macrophages. Consequently, a variety of cancer therapies directed against M-CSFR are under development. We set out to engineer chimeric antigen receptors (CARs) that employ the natural ligands of this receptor, namely M-CSF or interleukin (IL)-34, to achieve specificity for M-CSFR-expressing target cells. Both M-CSF and IL-34 bind to overlapping regions of M-CSFR, although affinity of IL-34 is significa

View details →DOI: 10.3390/cells11142190Cited by 10
Replication FailureOpen accessMedicine

Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial

Mette Kruse Klausen, Signe Justesen, Julie Niemann Pedersen et al. · 2026 · The Lancet

BACKGROUND: Alcohol use disorder accounts for 5% of deaths worldwide annually, and there is an urgent need for new therapeutic interventions. Preclinical and initial human studies indicate that the GLP-1 receptor agonist semaglutide might reduce alcohol drinking. This study evaluated the efficacy of semaglutide once-weekly in treatment-seeking patients with alcohol use disorder and comorbid obesity. METHODS: In a 26-week, single-centre, randomised, double-blinded, placebo-controlled trial, treatment-seeking participants with moderate to severe alcohol use disorder and comorbid obesity were ass

View details →DOI: 10.1016/s0140-6736(26)00305-3Cited by 9
Replication FailureOpen accessMedicine

Overall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer

Noor Wortelboer, Annemiek van Ommen-Nijhof, Inge R. Konings et al. · 2026 · JAMA Oncology

Importance: Cyclin-dependent kinase (CDK) 4 and 6 inhibitors (CDK4/6i) combined with endocrine therapy are widely used in hormone receptor (HR)-positive, ERBB2-negative advanced breast cancer (ABC). The SONIA trial evaluates the optimal…

View details →DOI: 10.1001/jamaoncol.2025.6585Cited by 9
Replication FailureOpen accessMedicine

A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer

Robert W. Lentz, Tyler J. Friedrich, Patrick J. Blatchford et al. · 2024 · Clinical Cancer Research

PURPOSE: In this single-institution phase II investigator-initiated study, we assessed the ability of MAPK and VEGF pathway blockade to overcome resistance to immunotherapy in microsatellite-stable metastatic colorectal cancer (MSS mCRC).…

View details →DOI: 10.1158/1078-0432.ccr-24-0090Cited by 9
Replication FailureMedicine

Prehospital Whole Blood in Traumatic Hemorrhage — A Randomized Controlled Trial

Jason Smith, Rebecca Cardigan, Emily Sanderson et al. · 2026 · New England Journal of Medicine

BACKGROUND: Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. METHODS: We conducted a pragmatic,…

View details →DOI: 10.1056/nejmoa2516043Cited by 9
Replication FailureOpen accessMedicine

Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes

Nicholas A. Marston, Erin A. Bohula, Ajay Bhatia et al. · 2026 · JAMA

Importance: Intensive lowering of low-density lipoprotein cholesterol (LDL-C) levels with PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors for cardiovascular event reduction has largely been reserved for patients with…

View details →DOI: 10.1001/jama.2026.3277Cited by 9
Replication FailureOpen accessPhysics and Astronomy

First Search for Ultralight Dark Matter Using a Magnetically Levitated Particle

D. W. P. Amaral, Dennis G. Uitenbroek, Tjerk H. Oosterkamp et al. · 2025 · Physical Review Letters

We perform the first search for ultralight dark matter using a magnetically levitated particle. A submillimeter permanent magnet is levitated in a superconducting trap with a measured force sensitivity of 0.2 fN/sqrt[Hz]. We find no evidence of a signal and derive limits on dark matter coupled to the difference between baryon and lepton number, B-L, in the mass range (1.10360-1.10485)×10^{-13} eV/c^{2}. Our most stringent limit on the coupling strength is g_{B-L}≲2.98×10^{-21}. We propose the POLONAISE (Probing Oscillations using Levitated Objects for Novel Accelerometry In Searches of Exotic

View details →DOI: 10.1103/physrevlett.134.251001Cited by 9
Replication FailureOpen accessSocial Sciences

Integrated Motivational Strategies for Intimate Partner Violence Perpetrators with Substance Use: A Randomized Controlled Trial

Cristina Expósito-Álvarez, Manuel Roldán-Pardo, Gail Gilchrist et al. · 2024 · Psychosocial Intervention

Objective: Intimate partner violence (IPV) perpetrators with alcohol and/or other drug use problems (ADUPs) have been identified as one of the main high-risk and highly resistant groups of perpetrators requiring special attention in…

View details →DOI: 10.5093/pi2024a13Cited by 9
Replication FailureOpen accessMedicine

Triple cardiovascular disease detection with an artificial intelligence-enabled stethoscope (TRICORDER) in the UK: a cluster-randomised controlled implementation trial

Mihir A Kelshiker, Patrik Bächtiger, Camille F Petri et al. · 2026 · The Lancet

BACKGROUND: Early detection of cardiovascular disease is a global public health priority. Artificial intelligence (AI)-enabled stethoscopes offer robust performance characteristics in point-of-care detection of heart failure, atrial fibrillation, and valvular heart disease (VHD). We conducted a pragmatic, cluster-randomised controlled implementation trial to determine the real-world effect and implementation challenges of AI-stethoscopes. METHODS: UK primary care practices were cluster randomised 1:1 to intervention (training and implementation in use of AI-stethoscopes in routine care) or con

View details →DOI: 10.1016/s0140-6736(25)02156-7Cited by 9
Replication Failure

Speckle tracking of left ventricle in pediatric patients with hemodynamically significant patent ductus arteriosus (PDA): case–control study

Ahmed Mahrous Kamal Baz, Osama Abd El-Fattah El-Agamy, Marwa Eldegwi et al. · 2024 · Egyptian Pediatric Association Gazette

Abstract Background Left ventricle (LV) volume overload is observed with hemodynamically significant PDA as it causes left to right shunting, leading to increased pulmonary blood flow. This overload causes LV remodeling as LV increases…

View details →DOI: 10.1186/s43054-024-00326-7Cited by 1
Replication FailureOpen accessMedicine

Analysis of the association between history of gestational diabetes mellitus and hypertensive disorders in a subsequent pregnancy: a retrospective cohort study.

Liu Y, Zhong S, Zhong K et al. · 2026 · Frontiers in endocrinology

Aim To investigate the association between history of gestational diabetes mellitus (GDM) and the risk of hypertensive disorders of pregnancy in subsequent pregnancy (s-HDP). Methods A retrospective cohort of 5, 928 women with two…

View details →DOI: 10.3389/fendo.2026.1736779
Replication FailureMedicine

Association of vitamin D deficiency with incident depression in patients with hearing impairment: an observational retrospective cohort study.

Cheng WJ, Kao CL, Hung IY · 2026 · Frontiers in nutrition

Background Hearing impairment is associated with an elevated risk of depression, yet modifiable risk factors in this population remain poorly characterized. Although vitamin D deficiency (VDD) has been linked to depression in general…

View details →DOI: 10.3389/fnut.2026.1856953
Replication FailureMedicine

[Adaptation Mechanism and Strategy of Ecological Resilience and High-quality Development in the Yellow River Basin].

Sheng YC, Chen X, Zhang YF et al. · 2026 · Huan jing ke xue= Huanjing kexue

Achieving ecological protection and high-quality development is the fundamental goal of sustainable development in the Yellow River Basin, and it is also an inevitable choice for the practice of the concept of Chinese-style modernization.…

View details →DOI: 10.13227/j.hjkx.202503345
Replication FailureMedicine

The effects of temperature, urbanisation, and artificial light on phototaxis in eusocial and non-eusocial bees.

Webster E, Ng L, Prendergast K et al. · 2026 · Journal of insect physiology

Climate change and urbanisation are major drivers of global insect pollinator decline. However, the combined effects of these stressors remain poorly understood, particularly in relation to pollinator behaviour. Understanding how these…

View details →DOI: 10.1016/j.jinsphys.2025.104927
Replication Failure

No Additional Benefit of 185 Hz versus 130 Hz at Equivalent Energy in Deep Brain Stimulation for Tremor - A randomized prospective clinical trial

van der Linden C, Trapp P, Dembek TA et al. · 2026 · Preprint

Background Deep brain stimulation (DBS) of the ventral intermediate nucleus and posterior subthalamic area (VIM/PSA) in Essential Tremor (ET) and the subthalamic nucleus (STN) in Parkinson’s disease (PD) are established treatment for…

View details →DOI: 10.64898/2026.05.31.26354199
Replication FailureMedicine

Facial shape and self-perceived personality traits in young adults.

Gkantidis N, Tsikouriadou E, Halazonetis D et al. · 2026 · Scientific reports

The present study investigated the association between facial shape and self-perceived personality and psychosocial traits. The study population consisted of 613 young adults (399 females and 214 males) aged 21-35 years, with similar…

View details →DOI: 10.1038/s41598-026-47895-8